Journal Article Practice Guideline Review Ppublish 3 citations
PubMed: 39657603 DOI: 10.1159/000543034
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies - Insulin Delivery.
Horm Res Paediatr 97(6):636-662
Authors: Torben Biester, Cari Berget, Charlotte Boughton, Laura Cudizio, Laya Ekhlaspour, Marisa E Hilliard, Leenatha Reddy, Suzanne Sap Ngo Um, Melissa Schoelwer, Jennifer L Sherr, Klemen Dovc
Affiliations
- AUF DER BULT, Hospital for Children and Adolescents, Hannover, Germany.
- Barbara Davis Center, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.
- Department of Pediatrics, Division of Pediatric Endocrinology, Santa Casa of São Paulo School of Medical Sciences, São Paulo, Brazil.
- Division of Endocrinology, Department of Pediatric, University of California San Francisco, San Francisco, California, USA.
- Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
- Department of Pediatrics Endocrinology, Rainbow Children's Hospital, Hyderabad, India.
- Department of Pediatrics, The University of Ebolowa, Mother and Child Center of the Chantal Biya Foundation, Yaounde, Cameroon.
- Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
- Department of Pediatrics, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
- Department of Endocrinology, Diabetes and Metabolic Diseases and University of Ljubljana Faculty of Medicine, University Medical Centre Ljubljana, University Children's Hospital, Ljubljana, Slovenia.
Abstract
The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and summarizes recent advances in the technology behind insulin administration, with special emphasis on insulin pump therapy, especially on glucose-responsive integrated technology that is feasible with the use of automated insulin delivery (AID) systems in children and adolescents. The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and summarizes recent advances in the technology behind insulin administration, with special emphasis on insulin pump therapy, especially on glucose-responsive integrated technology that is feasible with the use of automated insulin delivery (AID) systems in children and adolescents.
MeSH
Diabetes Mellitus, Insulin, Therapeutics
Cited by
- Glycemic Control in Children and Adolescents with Type 1 Diabetes: From Challenges to Innovation. Children (Basel), 2025
- Disparities in Time to Technology Initiation in the Year Following Diagnosis of Type 1 Diabetes Among Youth: A Retrospective Cohort Study. J Diabetes Sci Technol, 2026
- Case Report: Usefulness, effectiveness, and safety of an advanced hybrid closed-loop system in a child with early identification of type 1 diabetes. Front Endocrinol (Lausanne), 2025
- A Review of Real-World Evidence About the Use of Automated Insulin Delivery Systems in People With Type 1 Diabetes. Endocr Pract, 2025
- Early Stages of Automated Insulin Delivery. J Diabetes Sci Technol, 2025
- International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets. Horm Res Paediatr, 2025
- Risk of Hypoglycemia and Associated Factors Among In-Hospital Chinese Patients With Latent Autoimmune Diabetes in Adults (LADA): A Multicenter Retrospective Cohort Study. J Diabetes Res, 2026